VILDIABATE M 500

VILDIABATE M 500 is a combination oral antidiabetic medication that contains vildagliptin 50 mg and metformin 500 mg. This dual-ingredient tablet is specifically formulated to manage blood glucose levels in adults with type 2 diabetes mellitus. By combining vildagliptin 50 mg, a DPP-4 inhibitor, with metformin 500 mg, a first-line antidiabetic agent, VILDIABATE M 500 offers an effective and synergistic approach to achieving better glycemic control.

What is VILDIABATE M 500 (Tab Vildagliptin 50 mg and Metformin 500 mg)?

VILDIABATE M 500 is a fixed-dose combination tablet designed for adults with type 2 diabetes. It includes:

• Vildagliptin 50 mg tablet: Enhances the levels of incretin hormones, which stimulate insulin secretion and reduce glucagon production in a glucose-dependent manner.

• Metformin 500 mg: Works by decreasing glucose production in the liver and improving the body’s sensitivity to insulin.

This combination helps in managing both fasting and postprandial blood sugar levels without causing significant weight gain or hypoglycemia when used appropriately.

Uses of Vildagliptin 50 mg and Metformin 500 mg

The main vildagliptin 50 mg uses in combination with metformin 500 mg include:

• Treatment of Type 2 Diabetes Mellitus in adults whose blood sugar is not adequately controlled with lifestyle changes or monotherapy.

• Combination Therapy for patients needing dual treatment to improve glycemic control.

• Improved Postprandial Glucose Management, especially effective in reducing sugar spikes after meals.

Note: This medication is not intended for use in type 1 diabetes or diabetic ketoacidosis.

Side Effects of VILDIABATE M 500

Like all medications, tab vildagliptin 50 mg and metformin 500 mg may cause side effects in some individuals.

Common side effects:

• Nausea, vomiting, or mild gastrointestinal upset

• Diarrhea or bloating (mostly due to metformin)

• Headache or dizziness

• Metallic taste in the mouth

• Mild respiratory infections

Serious side effects (rare):

• Lactic acidosis (a rare but serious side effect of metformin)

• Liver enzyme abnormalities (vildagliptin-related)

• Hypoglycemia (more likely when used with insulin or sulfonylureas)

• Pancreatitis (rare)

Seek medical help immediately if you experience symptoms like severe stomach pain, jaundice, shortness of breath, or unexplained fatigue.

Precautions Before Using VILDIABATE M 500

Before using VILDIABATE M 500, inform your healthcare provider if you:

• Have kidney or liver impairment

• Are over 65 years of age (monitoring is advised)

• Have a history of heart failure or lactic acidosis

• Consume alcohol regularly

• Are pregnant, planning pregnancy, or breastfeeding

• Are scheduled for surgery or imaging procedures involving contrast dye

Routine blood sugar, kidney, and liver function tests are recommended while on this medication.

Drug Interactions – What Drugs Interact with Vildagliptin 50 mg and Metformin 500 mg?

VILDIABATE M 500 may interact with several medications. Inform your doctor if you are taking:

• Diuretics (e.g., furosemide): May increase risk of dehydration and kidney stress.

• ACE Inhibitors/ARBs (e.g., lisinopril, losartan): May increase the risk of angioedema.

• Beta-blockers (e.g., atenolol): Can mask symptoms of low blood sugar.

• Steroids and oral contraceptives: May interfere with blood sugar control.

• Alcohol: Increases the risk of lactic acidosis when taken with metformin.

• Iodinated contrast agents: May affect kidney function when used with metformin.

Always inform your healthcare provider about all medications and supplements you are taking.

Conclusion:

VILDIABATE M 500 combines the glucose-lowering benefits of vildagliptin 50 mg tablet and metformin 500 mg in one convenient dose. It is an effective and well-tolerated option for adults with type 2 diabetes who need enhanced glycemic control. For best results, use it in conjunction with a healthy diet, regular physical activity, and medical supervision.